Jasper Therapeutics- Warrants (24/09/2026) OverviewJasper Therapeutics- Warrants (24/09/2026) EBIT
EBIT (Earnings Before Interest and Taxes) analysis for JSPRW.
Quarterly EBIT
-$10.95M
↑ 49.77% YoY
As of Mar 31, 2026
Annual EBIT (TTM)
-$73.29M
↓ 567.45% YoY
Trailing 12 months ending Mar 31, 2026